Treatment-Free Interval (Tfi) After First-Line Therapy As A Prognostic And Predictive Factor In Malignant Pleural Mesothelioma (Mpm): Findings From The Ngr015 Phase Iii Trial With Ngr-Htnf Plus Best Investigator Choice (Bic) Versus Placebo Plus Bic.

Vanesa Gregorc,Domenico Ghio,Claudio Sallemi,Alessandra Bulotta,Gilda Rossoni,Maria G Viganò,Floriana Fontana,Gloria Rossoni,Scialini Colombi,Antonio Lambiase,Claudio Bordignon

JOURNAL OF CLINICAL ONCOLOGY（2015）

引用 2|浏览23

暂无评分

摘要

7557 Background: Historically, the TFI (time from end of first-line to start of second-line therapy) has been reported as a prognostic factor and predictive marker of benefit of next treatment line...

查看译文

关键词

malignant pleural mesothelioma,pleural mesothelioma,ngr015 phase iii trial,treatment-free,first-line,ngr-htnf

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要